Home/Use Cases/AI Patient Communication
Patient Experience

AI Patient Communication

AI patient communication tools handle appointment reminders, post-visit follow-up, prescription refill requests, and routine patient questions. The best tools maintain HIPAA compliance, integrate with the EHR, and let the practice approve AI-generated responses before they're sent.

Top tools for ai patient communication

5 tools
Common questions

Related searches

  • AI patient messaging
  • automated appointment reminders
  • AI patient follow-up
  • HIPAA patient communication AI
From the blog

AI Patient Communication: guides and analysis

Workflows

AI Is Answering Your Practice's Phone: The Call Workflow and Its Four Compliance Gates

Freed, Phreesia, and Hyro will all answer your phones now. But an inbound AI receptionist and an outbound AI caller are two different legal products — one is a HIPAA and recording-consent problem, the other is a TCPA problem worth $500 to $1,500 per call. Here is the full call workflow, the four gates where practices get hurt, and what these systems actually deflect.

Workflows

Your Patient Inbox Grew 153%. AI Drafts Are Not Fixing It — The Routing Is.

JAMA put a number on the inbox problem in June 2026: patient portal messages up 153% since 2020, office visits up 17%. The industry answer is AI draft replies — and four studies now show they save physicians almost no time, help nurses far more than doctors, and get worse as messages get longer. Here is the workflow that actually moves turnaround time, plus the e-visit billing trap and the disclosure rule that review-before-send quietly solves.

Guides

AI for the Front Desk in 2026: Cutting No-Shows, Phone Volume, and Front-Office Burnout

No-shows and missed calls are among the most preventable revenue losses in a practice, and AI scheduling and intake tools promise to fix both. We break down what actually works, what the ROI data does and does not show, and how to evaluate front-office AI for your practice.

Industry News

FDA's Generative AI Device Paper: What It Means for the AI Tools Your Practice Uses (Comments Due Oct. 19)

On August 18, 2026, FDA published its first detailed sketch of how it might regulate generative AI medical devices: a two-axis risk map, clinician-style competency testing, and more postmarket monitoring. It is not guidance and binds no one yet. Here is what it says, where scribes, CDS, patient chatbots and imaging tools land, what the first 'patient-facing LLM' clearance actually covered, and which of the 26 questions clinicians should answer before the October 19 deadline.

Guides

Your AI Scribe Lists 100+ Languages. It Still Isn’t Your Interpreter.

Multilingual AI scribes are real, but 2026 research shows clinicians skip them in interpreted visits, and when they are used, 55-60% of interpreter errors land in the note. Here is what Section 1557 still requires (including human review of machine-translated patient instructions), what each vendor documents, and a visit workflow that works.